phenylestertartrate,Rivastigminetartrate,S-RivastigminetartrateProperties:
| RelatedCategories | AnalyticalStandards,Analytical/Chromatography,EPStandards,EPStandardsP-R,Pharmacopeia&MetrologicalInstitutesStandards |
Description:
Caution
PleasefindSDSprovidedbyEDQMhere.
.
Generaldescription
ThisproductisprovidedasdeliveredandspecifiedbytheissuingPharmacopoeia.Allinformationprovidedinsupportofthisproduct,includingSDSandanyproductinformationleafletshavebeendevelopedandissuedundertheAuthorityoftheissuingPharmacopoeia.ForfurtherinformationandsupportpleasegotothewebsiteoftheissuingPharmacopoeia
.
OtherNotes
Salesrestrictionsmayapply.
Packaging
Unitquantity:1.0114mg.Subjecttochange.TheproductisdeliveredassuppliedbytheissuingPharmacopoeia.Forthecurrentunitquantity,pleasevisittheEDQMreferencesubstancecatalogue
.
Biochem/physiolActions
Rivastigmineisanorallyavailable,brainpenetrant,reversIBLecholinesteraseinhibitorthatenhancescognitivefunctioninpatientswithAlzheimer′sandParkinson′sdiseases.Rivastigmineinhibitsbothbutyrylcholinesteraseandacetylcholinesterase.
Safety:
RIDADR
NONHforallmodesoftransport